Study shows 2 doses of Sputnik vaccine better than Pfizer

A Russian and Italian study showed that neutralising antibodies against the Omicron last longer in people who have had the Sputnik V vaccine from Russia than in people with the Pfizer vaccine. The study was done on a very small scale though, with just 51 people who received the Sputnik V vaccine and only 17 people with Pfizer. It was also bankrolled by the Russian Direct Investment Fund, the same organization that markets the Sputnik V vaccine internationally.

The test compared the blood serum of the people who received the 2 different vaccines, both in Moscow at the Gamaleya Institute which developed the Sputnik V vaccine and at the Spallanzani Institute in Italy. The blood serum samples were taken between 3 and 6 months after the person had received the second dose of either the Sputnik or Pfizer vaccine.

The results of the researchers’ testing show that the antibodies were…